Comparison

SARS-CoV-2-IN-14 European Partner

€49.00
Excl. VAT
Item no. HY-144771-5mg
Manufacturer MedChem Express
CASRN 22203-98-1
Amount 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.02
Formula C13H9Cl2NO2
Citations [1]Juang YP, et al. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2. Eur J Med Chem. 2022 May 5;235:114295.
Smiles O=C(C1=C(C=CC(Cl)=C1)O)NC2=CC(Cl)=CC=C2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-anti-virus
Molecular Weight
282.12
Clinical Information
No Development Reported
Solubility
DMSO : 250 mg/mL (ultrasonic)
Pathway
Anti-infection
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
Listprice: €49.00
Price: €49.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close